PKM and breast carcinoma: Additionally, it has been demonstrated that breast cancer-derived exosomes can transfer miR-122-5p and suppress glucose uptake by niche cells through targeting the glycolytic enzyme pyruvate kinase (PKM), thus increasing nutrient availability for cancer cells in the premetastatic niche and promote tumor metastasis [39].